Avoid contact with the eyes and mucous membranes. Do not bandage tightly, wrap or cover until washing the area. It should not be applied to wounds or damaged skin. It should not be used immediately after bath. Wash hand thoroughly after applying.
Hypersensitivity to salicylate or any of its ingredients
Dose
N/A
Side Effect
Stinging/burning/tingling sensation of skin. Redness or irritation may occur, especially in persons with sensitive skin. Adverse reactions possibly involved are mild to moderate local irritation, erythema, rash, desquamation, pruritis and relative local reaction at the application site.
Pregnancy Category
Name :
C
Description
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks
Mode of Action
Anti-inflammatory, analgesia, local anesthesia. Menthol is used mainly for the symptomatic relief of sinusitis, bronchitis and similar conditions. It may be used as an inhalation, ointment or pastilles.
Interaction
Warfarin.
Pregnancy Category Note
N/A
Adult Dose
Topical
Adult: Apply to affected area not more than 3 to 4 times daily.
Child Dose
Topical
<12 years: Safety and efficacy not established
Children 12 years of age and older : Apply to affected area not more than 3 to 4 times daily.
Renal Dose
N/A
Administration
Apply a thin layer to the affected area and gently massage until cream disappears.
Disclaimer
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.